ФАКТОР РОСТА ЭНДОТЕЛИЯ СОСУДОВ: БИОЛОГИЧЕСКИЕ СВОЙСТВА И ПРАКТИЧЕСКОЕ ЗНАЧЕНИЕ (ОБЗОР ЛИТЕРАТУРЫ)
Аннотация
Об авторах
Н. Л. СветозарскийРоссия
А. А. Артифексова
Россия
С. Н. Светозарский
Россия
Список литературы
1. Carmeliet P. Angiogenesis in health and disease / Р. Carmeliet // Nat. Med. - 2003. - N 9. - P. 653-660.
2. Ferrara N. Angiogenesis as a therapeutic target / N. Ferrara, R. S. Kerbel // Nature. - 2005. - Vol. 438. - P. 967-974.
3. De Falco S. Antiangiogenesis therapy : an update after the first decade / S. De Falco // The Korean J. of Internal Medicine. - 2014. - N 29 (1). - P. 1-11.
4. Carmeliet P. Molecular mechanisms and clinical applications of angiogenesis / Р. Carmeliet, R. K. Jain // Nature. - 2011. - Vol. 473 (7347). - P. 298-307.
5. Folkman J. Angiogenesis : an organizing principle for drug discovery? / J. Folkman // Nature Reviews Drug Discovery. - 2007. - Vol. 6, N 4. - P. 273-286.
6. Ferrara N. Vascular endothelial growth factor : basic science and clinical progress / N. Ferrara // Endocr. Rev. - 2004. - Vol. 25. - P. 581-611.
7. Роль VEGF в развитии неопластического ангиогенеза / В. П. Чехонин [и др.] // Вестн. РАМН. - 2012. - № 2. - С. 23-34.
8. Герштейн Е. С. Современные представления о механизмах передачи сигналов факторов роста как основа эффективной молекулярно-направленной противоопухолевой терапии / Е. С. Герштейн, Н. Е. Кушлинский // Вопросы биологической, медицинской и фармацевтической химии. - 2007. - Т. 5, № 1. - С. 4-9.
9. Ferrara N. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells / N. Ferrara, W. J. Henzel // Biochem. Biophys. Res. Commun. - 1989. - Vol. 161 (2). - P. 851-8.
10. Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling / F. S. Grünewald [et al.] // Biochimica et Biophysica Acta. - 2010. - Vol. 1804 (3). - P. 567-580.
11. Vascular endothelial growth factor is a secreted angiogenic mitogen / D. W. Leung [et al.] // Science. - 1989. - Vol. 246 (4935). - P. 1306-9.
12. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene / N. Ferrara [et al.] // Nature. - 1996. - Vol. 380 (6573). - P. 439-42.
13. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice / A. K. Malik [et al.] // Blood. - 2006. - Vol. 107. - P. 550-7.
14. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation / H. P. Gerber [et al.] // Nat. Med. - 1999. - N 5. - P. 623-8.
15. Ferrara N. VEGF-A : a critical regulator of blood vessel growth / N. Ferrara // Eur. Cytokine Netw. - 2009. - Vol. 20 (4). - P. 158-63.
16. Ferrara N. The biology of VEGF and its receptors / N. Ferrara, H. P. Gerber, J. LeCouter // Nat. Med. - 2003. - Vol. 9 (6). - P. 669-76.
17. Carmeliet P. VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis / Р. Carmeliet, M. Simons // Dev. Cell. - 2010. - Vol. 18 (5). - P. 713-24.
18. Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer / А. А. Lanahan [et al.] // International J. of Molecular Sciences. - 2014. - Vol. 15 (12). - P. 23024-23041.
19. Niu G. Vascular Endothelial Growth Factor as an Anti-angiogenic Target for Cancer Therapy / G. Niu, X. Chen // Current drug targets. - 2010. - Vol. 11 (8). - P. 1000-1017.
20. The multifaceted circulating endothelial cell in cancer : towards marker and target identification / F. Bertolini [et al.] // Nat. Rev. Cancer. - 2006. - Vol. 6 (11). - P. 835-45.
21. Vascular and haematopoietic stem cells : novel targets for anti-angiogenesis therapy? / S. Rafii [et al.] // Nat. Rev. Cancer. - 2002. - Vol. 2 (11). - P. 826-35.
22. Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis / S. H. Lee [et al.] // Annals of Surgical Treatment and Research. - 2015. - Vol. 89 (1). - P. 1-8.
23. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer / А. Yuan [et al.] // J. Clin. Oncol. - 2001. - Vol. 19 (2). - P. 432-41.
24. Wang K. Prognostic value of vascular endothelial growth factor expression in patients with prostate cancer : a systematic review with meta-analysis / K. Wang, H. L. Peng, L. K. Li // Asian Pac. J. Cancer Prev. - 2012. - Vol. 13 (11). - P. 5665-9.
25. Prognostic role of vascular endothelial growth factor in prostate cancer : a systematic review and meta-analysis / Z. Q. Liu [et al.] // Int. J. Clin. Exp. Med. - 2015. - Vol. 8 (2). - P. 2289-98.
26. Hughes S. Vascularization of the human fetal retina : roles of vasculogenesis and angiogenesis / S. Hughes, H. Yang, T. Chan-Ling // Invest. Ophthalmol. Vis. Sci. - 2000. - Vol. 41 (5). - P. 1217-28.
27. Gariano R. F. Expression of angiogenesis-related genes during retinal development / R. F. Gariano, D. Hu, J. Helms // Gene Expr Patterns. - 2006. - Vol. 6 (2). - P. 187-92.
28. Vascular Endothelial Growth Factor in Eye Disease / J. S. Penn [et al.] // Progress in retinal and eye research. - 2008. - Vol. 27 (4). - P. 331-371.
29. West H. Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes / Н. West, W. D. Richardson, M. Fruttiger // Development. - 2005. - Vol. 132 (8). - P. 1855-62.
30. Diabetic Retinopathy : Vascular and Inflammatory Disease / F. Semeraro [et al.] // J. of Diabetes Research. - 2015. - Vol. 2015. - P. 582060.
31. Chong V. Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors / V. Chong // Ophthalmologica. - 2012. - Vol. 227. Suppl. 1. - P. 2-10.
32. Folkman J. Tumor angiogenesis : therapeutic implications / J. Folkman // N. Engl. J. Med. - 1971. - Vol. 285 (21). - P. 1182-6.
33. Anti-VEGF treatment for myopic choroid neovascularization : from molecular characterization to update on clinical application / Y. Zhang [et al.] // Drug Design, Development and Therapy. - 2015. - N 9. - P. 3413-3421.
34. Lu X. Profile of conbercept in the treatment of neovascular age-related macular degeneration / X. Lu, X. Sun // Drug Design, Development and Therapy. - 2015. - N 9. - P. 2311-2320.
35. Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer / X. Hu [et al.] // BMC Cancer. - 2014. - Vol. 14. - P. 820.
36. Ciombor K. K. Aflibercept / K. K. Ciombor, J. Berlin, E. Chan // Clinical cancer research : an official journal of the American Association for Cancer Research. - 2013. - Vol. 19 (8). - P. 1920-1925.
37. Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer / Т. В. Kristensen [et al.] // International J. of Molecular Sciences. - 2014. - Vol. 15 (12). - P. 23024-23041.
38. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) / U. Schmidt-Erfurth [et al.] // The British J. of Ophthalmology. - 2014. - Vol. 98 (9). - P. 1144-1167.
Рецензия
Для цитирования:
Светозарский Н.Л., Артифексова А.А., Светозарский С.Н. ФАКТОР РОСТА ЭНДОТЕЛИЯ СОСУДОВ: БИОЛОГИЧЕСКИЕ СВОЙСТВА И ПРАКТИЧЕСКОЕ ЗНАЧЕНИЕ (ОБЗОР ЛИТЕРАТУРЫ). Journal of Siberian Medical Sciences. 2015;(5):24.
For citation:
Svetozarskiy N.L., Artifeksova A.A., Svetozarskiy S.N. GROWTH PROMOTING FACTOR OF ENDOTHELIUM OF VESSELS: BIOLOGICAL PROPERTIES AND PRACTICAL VALUE (LITERATURE REVIEW). Journal of Siberian Medical Sciences. 2015;(5):24.